Live Chat Software
October 21, 2021 • 11:00 AM - 12:00 PM ET
As the patient journey evolves with the rise of specialty, oncology and rare disease states, paired with complexity of reimbursement, manufacturers are working hard to provide services throughout the patient journey.
- Hear strategies and best practices on how to provide an end-to-end experience that includes educating patients and investing in adherence
- Identify how to choose what services to insource vs. outsource to best meet your patient and business needs
Webinar Speakers
Bill Dupere
|
Bill Dupere
Practice Lead & Vice President, Market Access Solutions TrialCard |
Bill’s 25+ years of experience in the pharmaceutical industry includes an extensive background in clinical and regulatory affairs (CTL, Inc.); project, product and communications management (Burroughs Wellcome); niche life sciences consulting (ATOM, Inc., Campbell Alliance); and business and corporate development (LifeMetrix, US Oncology, Biologics). He served as COO of QOL Medical, a rare and orphan disease company.
Bill has deep therapeutic experience in oncology and rare diseases and extensive expertise in launching the first new products, services, business units, and companies in their respective industry sector. He has a passionate interest in understanding the implications of technology convergence, provider consolidation, and changing reimbursement paradigms with respect to patient access to personalized treatment.
He holds a B.S. in Public Health as well as an MBA from the University of North Carolina.
TrialCard
TrialCard Incorporated provides patient affordability, medication access and adherence, patient support, and clinical trial services on behalf of pharmaceutical manufacturers. Founded in 2000, TrialCard has connected nearly 33 million patients with over $15 billion in branded drug savings to date. The company is headquartered in Morrisville, North Carolina.